The research activities of the Sarcoma Team of the Oncology 1 Unit focuses on soft tissue and bone sarcoma research. Primary focus of sarcoma research at IOV is improving outcomes for patients diagnosed with this heterogeneous group of rare diseases, which involves studying new experimental treatments to improve survival as well as quality of life for patients diagnosed with sarcoma, even specific ultrarare subtypes, and the identification of prognostic and predictive marker of response to treatment which can help tailoring treatment.
These outcomes are pursued through collaboration with national and international groups, and in particular with Italian Sarcoma Group (ISG), Alleanza Contro il Cancro (ACC) and Associazione Italiana di Oncologia Medica (AIOM) in Italy; European Organization for Research and Treatment of Cancer (EORTC) and the European Reference Network (ERN) in Europe; and world sarcoma network, a more comprehensive research group which involves all major academic Centers worldwide contributing to sarcoma research.